From shaky to steady.
No incision. Real relief.
Connect your patients with an effective, safe and life-changing1 option for essential tremor and Parkinson’s disease.
The Science
Demonstrated safety and efficacy with clinical evidence
Technology
Exablate® Prime lets you precisely target locations deep inside the brain to treat movement disorders safely and effectively. In other words, you have the potential to change patients’ lives through the power of ultrasound.
That’s The Power
Of Prime
- Precision surgery
- No incisions
- Immediate response
Coverage Landscape for MRgFUS
Essential Tremor Coverage
268 million American lives covered by MRgFUS for essential tremor
Medicare Part B
Coverage in all 50 states
Commercial Payor Coverage
Anthem, Aetna, Cigna, Humana, Tricare, and 49 states under independent BCBS umbrella
Tremor Dominant Parkinson’s Disease (TPD) Coverage
61.7 million lives covered by MRgFUS for tremor predominant Parkinson’s disease
Medicare Part B
Coverage in 36 states
Commercial Payor Coverage
Anthem, Aetna
Advanced Parkinson’s Disease Coverage
47.1 million American lives covered by MRgFUS for advanced Parkinson’s with motor complications
Medicare Part B
Coverage in 10 states
Commercial Payor Coverage
Anthem
The Future of MR-guided Focused Ultrasound
Breakthroughs, patient stories, and clinical updates, delivered straight to your inbox.
1 Refers to significant improvement in qualify of life as demonstrated by the Insightec sponsored clinical trial
Safety Information:
Focused ultrasound treatment has been shown to be safe for treating essential tremor and Parkinson’s Disease certain indications, but as with any medical procedure, there are risks. For safety information, please visit: https://insightec.com/safety-information/. For detailed approved indications please visit: https://insightec.com/regulatory-approvals/
Results may not be representative of all treatment outcomes.
PRP-0000824 Rev 1